Amy Lynn Baxter

Principal investigator.

Digital health
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$1.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20192026
AwardsPatents
Federal awards as principal investigator

5 awards · $1.8M

DateAgencyAwardAmountCompany
May 19, 2026NIHSBIR Phase II
Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
$347KMMJ Labs, LLC
Jan 9, 2025NIHSBIR Phase II
Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
$456KMMJ Labs, LLC
Feb 14, 2023NIHSBIR Phase II
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.
$89KMMJ Labs, LLC
Mar 17, 2021NIHSBIR Phase II
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.
$689KMMJ Labs, LLC
Sep 18, 2019NIHSBIR Phase II
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.
$222KMMJ Labs, LLC
Among 907 researchers in Digital health

Peer ranks

Federal funding#229
Awards as PI#83
Patents#45
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.